학술논문

An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.
Document Type
Academic Journal
Source
Annals of Nuclear Medicine (ANN NUCL MED), Mar2022; 36(3): 267-278. (12p)
Subject
Language
English
ISSN
0914-7187